 | • レポートコード：D0-MOR-AP0290 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、連続製造の世界市場について調査・分析した資料で、連続製造の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
Continous manufacturing is gaining traction in the market due to its potential to improve its quality and consistency of medication at lower costs. Furthermore, the adaptation of continuous manufacturing in the pharma industry and rising demand for the medication due to the growing prevalence of diseases around the world are likely to propel the market growth.
Continous manufacturing help manufactures to meet the market demand at the same time which lowers the cost of manufacturing. Moreover, technological advancements in manufacturing and support from the government agencies are expected to bolster the market growth. In addition, product recalls and shortage of drugs are impelling the market growth. However, the slow adaptation of continuous manufacturing, lack of regulatory and technical clarity regarding guidelines are projected to impede the market growth in a negativa manner.
Key Market Trends
Integrated Continuous Manufacturing is Projected to Grow at Significant Rates
– Many pharmaceutical and healthcare manufacturing companies are adopting continuous manufacturing technologies having automation and minimal human interference.
– Furthermore, these integrated continuous manufacturing is benefiting the manufacturers by lowering the production costs, time and increasing their margin.
– In continuous manufacturing, raw materials are inserted into the system and the final product is produced in a continuous manner. This enables manufacturers to respond quickly to demand.
– The companies are largely investing in improving their existing manufacturing technologies and the rising number of pharmaceutical manufacturers are fuelling the market growth over the forecast period.
– Contract manufacturing organizations are expected to register a notable growth rate over the forecast period owing to the increase in the number of contract manufacturing organizations in developing regions.
– Moreover, the escalating number of drug approvals and need for more number of manufacturing facilities to meet the market demand is anticipated to boost the market growth.
North America Dominates the Market and is Expected to Continue the Same Over the Forecast Period
North America is projected to have a significant market share over the forecast period owing to the presence of key market players and the availability of advanced technologies. Furthermore, favorable regulatory infrastructure and high demand for medicine is projected to boost the market growth in the region. For instance, in February 2019, FDA has released draft guidelines for industry on continuous manufacturing of medicinal products. That covers all aspects of manufacturing. Moreover, high investment in research and development in pharma and biotechnological companies in the region is projected to boost the market growth in the region. The Asia Pacific region is believed to have robust growth opportunity owing to the developing healthcare infrastructure, low cost of raw material and manufacturing of the products especially in developing countries such as India.
Competitive Landscape
The continuous manufacturing market is moderately competitive having a limited number of manufacturers. The market players are focusing on merging the automation with the product manufacturing technologies to reduce the manufacturing costs and improve efficiency. The market players operating in market include GEA Group AG, Robert Bosch GmbH, Glatt GmbH, Thermo Fisher Scientific and Siemens.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Less Cost and Better Quality of Production
4.2.2 Support From Regulatory Authorities Around the World
4.3 Market Restraints
4.3.1 Lack of Regulatory and Technical Clarity
4.3.2 Slow adaptation and Rigidity Among the Industries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Integrated Continuous Manufacturing
5.1.2 Semi Continous Manufacturing
5.1.2.1 Continuous Blenders
5.1.2.2 Continuous Granulators
5.1.2.3 Continuos Coaters
5.1.2.4 Continuous Compressors
5.1.2.5 Continuous Dryers
5.1.2.6 Others
5.2 By Application
5.2.1 API Manufacturing
5.2.2 End Product Manufacturing
5.3 End User
5.3.1 Contract Manufacturers
5.3.2 Pharmacuitical Companies
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Siemens
6.1.2 GEA Group AG
6.1.3 Robert Bosch GmbH
6.1.4 Glatt GmbH
6.1.5 Thermo Fisher Scientific
6.1.6 Munson Machinery Co., Inc.
6.1.7 Coperion GmbH
6.1.8 Scott Equipment Company
6.1.9 HOSOKAWA MICRON CORP.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS